Evidence map›Paper›PMID 34324927›Full record

ArticleJournal of cardiac failure2022

Quantifying the Impact of Atrial Fibrillation on Heart Failure-Related Patient-Reported Outcomes in the Utah mEVAL Program.

Benjamin A Steinberg, Mingyuan Zhang, Jason Bensch, Ann Lyons, T Jared Bunch, Jonathan P Piccini, Alfonso Siu, John A Spertus, Josef Stehlik, Peter Wohlfahrt and 3 more

Abstract read
In one paragraph

Article in Journal of cardiac failure, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Benjamin A SteinbergUniversity of Utah Health Sciences Center, Salt Lake City, Utah. Electronic address: benjamin.steinberg@hsc.utah.edu.
Mingyuan ZhangUniversity of Utah Health Sciences Center, Salt Lake City, Utah.
Jason BenschUniversity of Utah Health Sciences Center, Salt Lake City, Utah.
Ann LyonsUniversity of Utah Health Sciences Center, Salt Lake City, Utah.
T Jared BunchUniversity of Utah Health Sciences Center, Salt Lake City, Utah.
Jonathan P PicciniDuke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina.
Alfonso SiuUniversity of Utah Health Sciences Center, Salt Lake City, Utah.
John A SpertusSaint Luke's Mid America Heart Institute/UMKC, Kansas City MO.
Josef StehlikUniversity of Utah Health Sciences Center, Salt Lake City, Utah.
Peter WohlfahrtUniversity of Utah Health Sciences Center, Salt Lake City, Utah.
Tom GreeneUniversity of Utah Health Sciences Center, Salt Lake City, Utah.
Rachel HessUniversity of Utah Health Sciences Center, Salt Lake City, Utah.
James C FangUniversity of Utah Health Sciences Center, Salt Lake City, Utah.

Funding

Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0M
Optimizing Outcomes for Patients with Heart Failure and Atrial FibrillationK23HL143156 · NHLBI · UNIVERSITY OF UTAH · PI STEINBERG, BENJAMIN ADAM · 2018 to 2022
$951k
NCATS NIH HHS UL1 TR002538NHLBI NIH HHS K23 HL143156
6 · The paper itself

Abstract

backgroundAtrial fibrillation (AF) frequently complicates heart failure (HF), and each is associated with lower overall health-related quality of life. We aimed to quantify the incremental burden of AF on the health-related quality of life of patients with HF in clinical practice. METHODS AND

resultsWe used data from the Utah mEVAL program to analyze patient-reported outcomes (PROs) among patients with HF with and without AF. The primary outcome was the HF-specific Kansas City Cardiomyopathy Questionnaire, with generic PROs as secondary outcomes. Among 1707 patients with HF, 36% had AF (n = 616). Those with HF and AF were older (mean age 69 years vs 58 years, P < .001), more likely to have prior stroke (29% vs 17%, P < .001) and ischemic cardiomyopathy (28% vs 23%, P = .01), but had similar ejection fractions (mean 44% each, P = .6). After adjustment, and compared with HF alone, HF with AF was associated with worse Kansas City Cardiomyopathy Questionnaire scores (adjusted mean difference -3.45, 95% confidence interval [CI] -6.24 to -0.65), and worse Patient-Reported Outcomes Measurement Information System physical function scores (adjusted mean difference -1.63, 95% CI -2.59 to -0.67). The difference in visual analog scale general health was borderline (adjusted mean difference -2.01, 95% CI -4.51 to 0.49), and Patient-Reported Outcomes Measurement Information System depression scores were similar (adjusted mean difference 0.54, 95% CI -0.48 to 1.57).

conclusionsAF complicates nearly one-third of HF cases, and patients with HF and AF are substantially older and sicker. After adjustment, AF was independently associated with worse disease-specific and overall health-related quality of life than HF alone. Whether maintaining sinus rhythm can improve the HF-related health status of patients with HF in clinical practice should be explored further.

Indexed as

Atrial FibrillationHeart FailurePatient Reported Outcome MeasuresAgedHumansMiddle AgedQuality of LifeStroke VolumeUtahValineN-methylvalineValineAtrial fibrillationhealth-related quality of lifeheart failurepatient-reported outcomes

Identifiers

PMID34324927
PMCPMC8748275

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.